H3 K27M-mutant diffuse midline glioma with osseous metastases: A case report and a literature review.

IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY
Sarah Al Sharie, Muna Talafha, Dima Abu Laban, Tala Al Awabdeh, Abdullatif Al-Mousa, Nidal Al-Masri, Maysa Al-Hussaini
{"title":"H3 K27M-mutant diffuse midline glioma with osseous metastases: A case report and a literature review.","authors":"Sarah Al Sharie,&nbsp;Muna Talafha,&nbsp;Dima Abu Laban,&nbsp;Tala Al Awabdeh,&nbsp;Abdullatif Al-Mousa,&nbsp;Nidal Al-Masri,&nbsp;Maysa Al-Hussaini","doi":"10.5414/NP301475","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Diffuse midline glioma (DMG) is a primary tumor of the central nervous system (CNS) with aggressive nature. It arises from midline structures in the brain and spinal cord. Recently, the presence of H3 K27M mutation is described in most cases. Extra-cranial osseous metastasis is rarely encountered.</p><p><strong>Case presentation: </strong>We present an interesting case of DMG with bone metastasis at presentation in a 19-year-old male. In addition, a literature review on similar cases is presented.</p><p><strong>Discussion: </strong>DMG mostly affects children and young adults. It has a broad spectrum of phenotypes, shows diffuse growth pattern, midline location, and is frequently H3 K27M-mutant. Radiotherapy remains the mainstay of treatment that might improve overall survival. Metastasis outside the CNS remains a rare occurrence, especially at presentation, and constitute a diagnostic challenge.</p><p><strong>Conclusion: </strong>Bone is one of the most common sites for metastasis of primary CNS tumors, which would severely impact prognosis. Oncologists, radiologists, and pathologists should keep an index of suspicion when encountering bone metastasis in the presence of a CNS midline tumor, so that timely diagnosis and management can be rendered.</p>","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":null,"pages":null},"PeriodicalIF":0.8000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neuropathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5414/NP301475","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 2

Abstract

Introduction: Diffuse midline glioma (DMG) is a primary tumor of the central nervous system (CNS) with aggressive nature. It arises from midline structures in the brain and spinal cord. Recently, the presence of H3 K27M mutation is described in most cases. Extra-cranial osseous metastasis is rarely encountered.

Case presentation: We present an interesting case of DMG with bone metastasis at presentation in a 19-year-old male. In addition, a literature review on similar cases is presented.

Discussion: DMG mostly affects children and young adults. It has a broad spectrum of phenotypes, shows diffuse growth pattern, midline location, and is frequently H3 K27M-mutant. Radiotherapy remains the mainstay of treatment that might improve overall survival. Metastasis outside the CNS remains a rare occurrence, especially at presentation, and constitute a diagnostic challenge.

Conclusion: Bone is one of the most common sites for metastasis of primary CNS tumors, which would severely impact prognosis. Oncologists, radiologists, and pathologists should keep an index of suspicion when encountering bone metastasis in the presence of a CNS midline tumor, so that timely diagnosis and management can be rendered.

H3 k27m突变型弥漫性中线胶质瘤伴骨转移1例报告并文献复习。
弥漫性中线胶质瘤(DMG)是一种侵袭性中枢神经系统(CNS)的原发性肿瘤。它起源于大脑和脊髓的中线结构。近年来,H3 K27M突变在大多数病例中被描述。颅外骨转移是罕见的。病例报告:我们报告了一个有趣的病例,DMG伴有骨转移的表现在一个19岁的男性。此外,还对类似病例进行了文献综述。讨论:DMG主要影响儿童和年轻人。它具有广泛的表型,表现为弥漫性生长模式,中线位置,并且经常是H3 k27m突变体。放疗仍然是可能提高总生存率的主要治疗方法。中枢神经系统外转移仍然是罕见的,特别是在表现,并构成诊断挑战。结论:骨是原发性中枢神经系统肿瘤最常见的转移部位之一,严重影响预后。当遇到伴有中枢神经系统中线肿瘤的骨转移时,肿瘤科、放射科和病理学家应保持怀疑指数,以便及时诊断和处理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Neuropathology
Clinical Neuropathology 医学-病理学
CiteScore
1.60
自引率
0.00%
发文量
70
审稿时长
>12 weeks
期刊介绍: Clinical Neuropathology appears bi-monthly and publishes reviews and editorials, original papers, short communications and reports on recent advances in the entire field of clinical neuropathology. Papers on experimental neuropathologic subjects are accepted if they bear a close relationship to human diseases. Correspondence (letters to the editors) and current information including book announcements will also be published.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信